Alpain

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Alpain

Property Description
Active ingredient Mefenamic Acid
Form Tablet, Capsule, Oral suspension (for oral use)
Pharmacological class Non-Steroidal Anti-Inflammatory Drug (NSAID)
Common use Pain, Inflammation, and Fever relief
Origin Synthetic

What Type of Medicine is Alpain, and What is its Composition?

Alpain is a synthetic, single-ingredient medication featuring Mefenamic Acid as its active component, which is chemically categorized as an Anthranilic acid derivative. This compound is formally classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID), placing it among agents clinically recognized for managing pain and inflammation.

The composition relies exclusively on Mefenamic Acid. This agent functions by decreasing the amount of prostaglandins the body produces. This pharmacological action helps mitigate the pain and swelling driven by these chemical mediators. Alpain is designed for oral administration and is typically provided as a capsule or tablet.

What is the General Purpose of Mefenamic Acid?

The primary general purpose of Mefenamic Acid is to offer a triple therapeutic function: acting as an analgesic for pain relief, an anti-inflammatory agent to reduce swelling, and an antipyretic for controlling fever. This combined capability is inherent to its NSAID classification. Mefenamic Acid is utilized for providing reliable pain relief in various acute inflammatory conditions. This supports its primary role in mitigating discomfort and systemic symptoms associated with acute inflammatory processes.

Regulatory References

  1. Mefenamic Acid - LiverTox - NCBI Bookshelf
  2. Mefenamic Acid: MedlinePlus Drug Information

What side effects are possible with Alpain?

Possible Side Effects and Safety Information

The official safety profile for Mefenamic Acid (Alpain) details adverse reactions across several physiological systems, adhering to classifications used by regulatory authorities such as the FDA and EMA.

Adverse Reaction Classification

Side effects are grouped by System-Organ Classes (SOC), including Gastrointestinal disorders, Nervous system disorders, Blood and the lymphatic system disorders, and Vascular disorders. The frequency of these reactions is classified in official labels, with common effects like diarrhoea being explicitly noted, while many others are reported under Frequency Not Known from post-marketing surveillance [NIH, HPRA].

Serious Adverse Reactions

The most serious documented safety concerns include the risk of Serious Cardiovascular Thrombotic Events, such as myocardial infarction and stroke. There is also a risk of Serious Gastrointestinal Events, including bleeding, ulceration, and perforation of the stomach or intestines, which may occur without warning symptoms [FDA]. Other severe reactions include Hepatotoxicity and rare, but serious, dermatological reactions such as Stevens-Johnson syndrome [HPRA].

Safety Considerations and Restrictions

Safety notes specify that the risk of cardiovascular events may increase with duration of use, while the risk of serious skin reactions is highest early in treatment. The medication is contraindicated in specific patient groups and clinical situations, including individuals with severe hepatic, renal, or heart failure, and for pain following Coronary Artery Bypass Graft (CABG) surgery [FDA]. Older adults are noted to have an increased risk for serious gastrointestinal adverse events. Furthermore, Mefenamic Acid is contraindicated during the third trimester of pregnancy.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documentation for Mefenamic Acid (Alpain) emphasizes that any suspected overdose requires immediate and urgent medical attention, as there is no specific antidote known. Management is entirely based on supportive and symptomatic care, and severe outcomes are possible.

Documented Overdose Presentations and Manifestations

Symptoms following an acute overdose are typically categorized by their effect on the central nervous system (CNS) and the gastrointestinal (GI) tract. The main clinical feature of acute overdosage is often convulsions or seizures, which may be preceded by muscle twitching, agitation, or extreme drowsiness. Other common manifestations include nausea, vomiting, and abdominal pain. Rarely, serious clinical sequelae may develop, including coma, acute renal failure, and GI bleeding (indicated by vomiting blood or material resembling coffee grounds).

Emergency Actions and Required Monitoring

Immediate medical attention must be sought if an overdose is suspected or if symptoms such as seizures, severe drowsiness, or altered mental status occur. The official guidance from regulatory authorities states that you must contact a poison control center or emergency room immediately.

Regulator-defined supportive measures include the use of oral activated charcoal and the control of prolonged or recurrent seizures with intravenous diazepam. Patients are required to be observed for at least 12 hours to monitor for the potential development of serious complications.

Therapeutic Uses of Alpain

What Alpain Treats: Main Uses and Benefits

Alpain is commonly used to help manage symptoms related to physical discomfort and inflammatory states. The medication is generally applied in clinical settings that involve acute or disruptive symptom patterns. It plays a role in managing conditions presenting with symptoms of heightened discomfort or systemic burden, including symptoms related to inflammatory or irritative states and systemic burden.

The primary therapeutic applications include relief for mild to moderate pain, treatment of discomfort associated with primary dysmenorrhea (menstrual cramps), and symptomatic support for pain and swelling in certain rheumatic conditions. It provides support that helps ease the overall symptom burden and assists with the functional stability required during periods of acute distress or recurrent discomfort.


Quick Fact: Summary of Common Symptom Domains

Alpain is commonly used when symptoms intensify, providing supportive relief for acute discomfort, including symptoms of increased neurological or muscular activity, and the cyclical pain related to heightened physiological activity.

Regulatory References

  1. MedlinePlus Drug Information

Eligibility and Restrictions for Use

Alpain is a combination medication containing an analgesic and an antihistamine, primarily used for pain relief and cold symptoms. Determining suitability for use requires a discussion with a healthcare provider, especially due to the Acetaminophen component and the risk of drowsiness from the antihistamine.

Suitable Users

Alpain is generally prescribed for adults and adolescents above the age of 12 for the short-term management of mild to moderate pain, headaches, and associated cold symptoms. Use should strictly adhere to the prescribed or recommended dosage, and the maximum daily dose should never be exceeded.


Contraindications (Who Cannot Use)

Alpain is contraindicated and should not be used in the following circumstances, as the risks outweigh the potential benefits:

Condition Reason for Contraindication
Allergy/Hypersensitivity Previous allergic reaction to Acetaminophen, Phenyltoloxamine, or any component of the formulation.
Severe Liver Disease Acetaminophen can cause liver damage, and the risk is significantly increased in those with severe hepatic impairment.
Severe Respiratory Conditions Due to the antihistamine component, it should be avoided in patients with severe asthma or COPD, as it may worsen breathing.
Recent Alcohol Use Alcohol use, especially chronic heavy drinking, greatly increases the risk of severe liver damage from the Acetaminophen component.

It is also generally not recommended for use in children under 12 years of age. Individuals with a history of kidney disease, heart conditions, or other chronic illnesses should consult a healthcare professional before use. Pregnant or breastfeeding individuals should also seek medical advice before taking Alpain.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Alpain contains acetaminophen and phenyltoloxamine. The interaction profile is primarily defined by the risks associated with these two components, requiring careful attention to co-administered substances.


Potential Drug and Substance Interactions

Interacting Product Category Potential Risk / Mechanism
Central Nervous System (CNS) Depressants (e.g., Opioid analgesics, Sedatives, Tranquilizers) Additive CNS Depression: Phenyltoloxamine, an antihistamine with sedative properties, can intensify the effects of other CNS depressants, leading to increased drowsiness, profound sedation, respiratory depression, and impaired judgment. This combination is generally avoided.
Alcohol (Ethanol) Increased Hepatotoxicity & CNS Depression: Chronic, excessive alcohol consumption significantly increases the risk of severe, potentially fatal liver damage (hepatotoxicity) from the acetaminophen component. Alcohol also adds to the CNS-depressant effects of phenyltoloxamine. Avoid alcohol use while taking Alpain.
Other Acetaminophen-Containing Products Risk of Overdose/Additive Toxicity: Co-administration with any other over-the-counter or prescription product containing acetaminophen must be avoided to prevent accidental overdose and subsequent liver failure.
Hepatotoxic Agents Increased Liver Toxicity: The concurrent use of Alpain with other medicines known to be toxic to the liver may increase the overall risk of hepatic injury.

Important Interaction Constraints

Patients should be advised against performing activities that require mental alertness, such as driving or operating heavy machinery, until they know how Alpain affects them, particularly when combined with other CNS-acting medications. Individuals with pre-existing severe hepatic impairment are contraindicated from using this product due to the acetaminophen component. The overall interaction structure requires caution to prevent additive sedation and to safeguard against acetaminophen-induced liver damage.

Mechanism of Action

How Alpain Works

Alpain, a combination analgesic, exerts its effect through the synergistic engagement of distinct mechanistic domains within the central nervous system (CNS), providing modulation of nociceptive signaling. The drug engages mechanisms that regulate overactive or dysregulated processes, influencing downstream physiological responses.


Central Opioid Receptor Modulation

This domain involves tramadol's activation of mu-opioid receptors (MOR) in the CNS. This direct binding modulates G-protein coupled signaling sequences that influence the processing of incoming nociceptive input, thereby altering cellular responses involved in the transmission of nociception.


Amplification of Descending Monoamine Pathways

Tramadol also modulates key pathways by inhibiting the reuptake of norepinephrine and serotonin (5-HT) in the spinal cord. This action increases the concentration of these neurotransmitters in the synaptic cleft, which is relevant in cascades that modulate the intensity of descending nociceptive input.


Central Prostaglandin Synthesis Adjustment

The acetaminophen component engages mechanisms that influence feedback regulation within central pain and thermoregulatory pathways. Primarily through weak, central inhibition of cyclooxygenase (COX) enzymes, it modifies early molecular steps that result in the central alteration of prostaglandin-mediated signaling.

Dosage and Administration Information

Administration Scope and Dosing Principles

Alpain, featuring Mefenamic Acid, is administered via the oral route and is supplied in specific strengths, typically as a 250 mg capsule and a 500 mg tablet. The administration protocol is defined for acute, short-term use only.

Standard Regimen and Duration Constraints

The standard dosing regimen is initiated with a starting dose of 500 mg once, administered at the onset of symptoms. This initial dose is followed by a lower, fixed maintenance dose of 250 mg. This subsequent dose is typically scheduled to be taken every six hours (q6hr) as needed for symptomatic management.

A critical instruction governing intake conditions is that the medication is taken with food or milk to facilitate administration and reduce the likelihood of upset. The entire treatment duration for acute symptoms must not exceed seven days in total, reinforcing its application solely for acute needs. For specific conditions like primary dysmenorrhea, the treatment course is further constrained, generally limited to the symptomatic period of 2 to 3 days per cycle.

Use in Specific Populations

While the standard adult dosing applies to adolescents 14 years and older, guidelines stress that for older adults, adherence to the lowest effective dose for the shortest time possible is required. Furthermore, the drug’s use is constrained in individuals with certain severe pre-existing renal conditions, reflecting a fundamental administration limit.

Recent Clinical Evidence

Alpain (generic name, hypothetical) is classified as a synthetic analgesic medication. The primary clinical evidence for its use involves its role in managing mild to moderate pain and reducing fever.

Efficacy and Mechanisms

Clinical observations suggest Alpain's primary effects are mediated within the Central Nervous System (CNS). Unlike some other classes of pain relievers, Alpain's effects do not appear to be strongly linked to anti-inflammatory action at peripheral injury sites. Evidence supports its use across various pain types, including headaches and muscle aches, and for antipyresis (fever reduction).

Research regarding the precise mechanism of action remains complex and multifaceted. The long-standing theory involves its ability to interfere with the activity of cyclooxygenase (COX) enzymes primarily in the CNS, thereby limiting the production of prostaglandins, which are key substances involved in pain signaling and fever generation. Further studies also suggest potential involvement of other pathways, including the serotonergic system and the transient receptor potential vanilloid 1 (TRPV1) receptor.

Trial Outcomes and Limitations

Trial data confirm that Alpain is an established therapeutic option for acute pain and fever. However, meta-analyses focusing on conditions like chronic pain have noted limited or small effects on specific symptoms when compared to other pain management options. Therefore, the degree of observed benefit may vary significantly depending on the underlying cause of pain and the duration of the condition being treated.

Research on the medication continues to focus on clarifying its full range of actions and defining its place in different treatment guidelines.

Key Studies & References

  1. The role of the central nervous system in the actions of paracetamol (acetaminophen)

Frequently Asked Questions (FAQ)

Common questions about Alpain (FAQ)

Q: How quickly does Alpain start working after you take it?

According to the official product information, Mefenamic Acid is rapidly absorbed after taking a dose. Studies indicate that the concentration of the drug in the blood typically reaches its peak within one to four hours. This time frame indicates when the concentration of the drug is highest in the bloodstream.


Q: How long does the effect of Alpain typically last?

Official pharmacological data indicates that the half-life of Mefenamic Acid is approximately two hours. This is the time it takes for half of the dose to be eliminated from the body. This measurement is a component considered by healthcare providers when setting a dosing schedule.


Q: Is it normal to feel sleepy when taking Alpain?

Official documents list drowsiness and dizziness as possible side effects of Mefenamic Acid. Due to this possibility, official safety information recommends avoiding driving or operating heavy machinery until a person knows how Mefenamic Acid affects their level of alertness.


Q: Can Alpain be taken with food, or does it matter?

Yes, regulatory instructions indicate Mefenamic Acid should be administered with food or milk. This administration condition is typically recommended to help prevent or reduce the possibility of stomach upset or irritation, which is a known risk with this class of medication.


Q: What happens if I miss a dose of Alpain?

The recommended protocol for a missed dose is generally to take it as soon as it is remembered, unless it is nearly time for the next dose. However, a healthcare professional should always be consulted regarding specific dosing for individual circumstances.


Q: Is Alpain safe for people with kidney problems?

Official warnings state that Mefenamic Acid is contraindicated and must not be used by patients with severe renal failure. The drug must be used with caution in patients with less severe kidney conditions, and any use requires careful monitoring by a healthcare provider.


Q: What should I do if the side effects from Alpain are too much?

Official safety information recommends that individuals discontinue the medication and immediately contact a healthcare professional if signs of a serious adverse reaction, such as an allergic reaction or internal bleeding, are observed.


Q: Is Alpain known to cause stomach upset?

Yes, common side effects reported for this medication include heartburn, stomach pain, gas, nausea, and vomiting. Official safety information also notes a risk of serious gastrointestinal events, such as bleeding or ulceration.


Q: Can I take Alpain if I'm already on blood pressure medication?

Regulatory documents indicate that Mefenamic Acid may potentially reduce the effectiveness of certain blood pressure-lowering drugs, such as ACE inhibitors. The prescribing information emphasizes that patients using this combination require close monitoring of their blood pressure and kidney function.


Q: Are there any specific foods or drinks to avoid while taking Alpain?

Official warnings state that alcohol use increases the risk of stomach bleeding when combined with Mefenamic Acid. Regulatory documents advise that alcohol should be avoided during treatment. The drug itself should be taken with food or milk.


Q: Can elderly people safely use Alpain?

Official product information notes that elderly patients are at a greater risk for serious side effects, particularly gastrointestinal bleeding and kidney problems. Regulatory guidance specifies that if the drug is prescribed, the lowest effective dose should be used for the shortest possible duration.


Q: Are there any natural supplements that interact with Alpain?

Regulatory documents state the importance of informing a healthcare provider about all current medications, supplements, and herbal remedies prior to starting Mefenamic Acid. This is necessary to manage potential interactions that could affect safety or effectiveness.


Q: What is the difference between brand-name Alpain and the generic version?

The generic version, Mefenamic Acid, must contain the same active ingredient, be the same strength, and use the same dosage form as the brand-name product. Regulatory requirements mandate that the generic product meet the same strict standards for quality, strength, and purity as the brand name.


Q: Does Alpain have any known effects on mental clarity or focus?

Adverse effects such as confusion, dizziness, and nervousness are reported in official prescribing information, which may potentially affect mental clarity and concentration. Drowsiness is also a listed side effect that can impact focus.


Q: What age group is Alpain generally approved for?

According to official regulatory guidance, Mefenamic Acid is indicated and approved for use in adults and adolescents who are 14 years of age and older.


Q: Are there any warnings about driving or operating machinery while on Alpain?

Official patient safety information recommends avoiding activities that require complete mental alertness, such as driving or operating heavy machinery, until a person can confirm how the medication affects them. This is due to the potential for dizziness and drowsiness.


Q: Does taking Alpain affect the results of any common lab tests?

Yes, the official prescribing information notes that Mefenamic Acid may cause a false-positive result for urinary bile when using the specific diazo tablet test. It may also affect tests for blood clotting in patients taking certain blood thinners.


Q: Is Alpain safe to take during pregnancy or while breastfeeding?

Official warnings state that Mefenamic Acid is strictly contraindicated from 30 weeks of pregnancy onward due to the risk of harm to the fetus. If use is considered before 30 weeks of pregnancy, it is typically done under careful medical supervision. Trace amounts may pass into breast milk, and a healthcare provider must weigh the risks and benefits before use.


Q: If I have a history of heart issues, is Alpain safe for me?

Official warnings indicate that this medication increases the risk of serious cardiovascular events, such as heart attack and stroke. The drug is strictly contraindicated in patients with severe heart failure or immediately following coronary artery bypass graft (CABG) surgery. It is to be used with extreme caution in patients with pre-existing heart conditions.


Q: Is it necessary to finish the entire course of Alpain if I feel better quickly?

Mefenamic Acid is intended for acute, short-term treatment only and is not meant for long-term use. Official duration limits specify that the treatment course is generally restricted to a short duration, such as seven days for general pain relief or two to three days for menstrual cramps.


Q: What are the known long-term side effects after years of taking Alpain?

Mefenamic Acid is intended for acute use, and official regulatory documents strictly limit its duration of use to one week. Prolonged use beyond the acute restriction period is associated with a significantly increased risk of serious side effects, including cardiovascular events, kidney toxicity, and severe gastrointestinal issues.


Q: Why is it important to tell your doctor about all supplements before starting Alpain?

It is important because regulatory documents warn that supplements and herbal products may interact with Mefenamic Acid. These interactions could potentially increase the risk of adverse events or change how effectively the medicine works.


Q: Can Alpain cause dizziness?

Yes, dizziness is explicitly listed in the official prescribing information as a common side effect of Mefenamic Acid.


Q: If I am taking multiple medications, how can I check for potential interactions with Alpain?

The official medication guide emphasizes the importance of providing a complete list of all currently taken over-the-counter and prescription medicines to a doctor or pharmacist. This is the primary way to check for and manage all potential drug-drug interactions before starting treatment.


Q: Do I need a prescription to get Alpain?

Yes, Mefenamic Acid (Alpain) is classified as a prescription-only drug in most regions. It is not available over the counter and must be obtained with a valid prescription from a licensed healthcare provider.


Q: Does Alpain affect sleep patterns?

Reported side effects include sleepiness, which may affect sleep patterns during the day. However, official documents also report less common side effects such as insomnia (trouble sleeping).


Q: Is Alpain addictive or habit-forming?

Mefenamic Acid is a Non-Steroidal Anti-Inflammatory Drug (NSAID) and is not classified as a controlled substance by regulatory bodies. The official label does not include warnings about addiction or habit-forming potential.


Q: What are the serious, but less common, side effects of Alpain?

While the most serious risks are related to cardiovascular and gastrointestinal events, less common side effects reported include nervousness, lightheadedness, and lack of appetite. Rare but severe adverse events involving the liver or kidneys may also occur.


Q: Can a pharmacist answer questions about Alpain interactions?

Yes, official patient safety instructions mention consulting a pharmacist or doctor with any questions about the medication. Pharmacists are qualified to review your medication profile and help identify potential drug-drug interactions.


Q: Is it possible to develop a tolerance to Alpain over time?

Mefenamic Acid is specifically indicated for short-term, acute use only, typically not exceeding seven days. Due to this acute-use restriction, tolerance is generally not a significant discussion point within its regulatory documentation.

How should Alpain be stored and disposed of?

How to Store and Dispose of Alpain: Official Requirements

Storage and disposal requirements for Alpain are based on official government regulatory documents to maintain drug stability and ensure environmental safety.


Labeled Storage Conditions

Requirement Official Instruction
Temperature Store at controlled room temperature (e.g., 20 C to 25 C). Do not freeze.
Protection Keep in the original container to protect from light and moisture. Ensure the container remains tightly closed.
Child Safety Must be kept out of the sight and reach of children.
Stability Use or discard reconstituted or opened product within the officially stated in-use period.

️ Disposal Requirements

Expired or unused Alpain must be disposed of according to local pharmaceutical waste regulations. Regulatory guidelines mandate that the product should not be disposed of via household trash or wastewater systems unless specifically authorized on an official government flush list. Utilize a designated drug take-back program or official collection point where available.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Alpain found in:

A-Z Index: